Our location at Hollywood is a modern state of the art research facility.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5245 for the Treatment of COVID-19 in Nonhospitalized Participants.
Join our clinical study and help us find new solutions for managing asthma symptoms.
If you know someone who has schizophrenia and is displaying negative symptoms, including a lack of drive and motivation and limited interaction with others, learn about this research study evaluating an investigational drug for negative symptoms of schizophrenia (NSS).
Fed up with painful eczema or atopic dermatitis flare ups? Your eczema or atopic dermatitis just won't quit. But neither will you. See if you may be eligible to participate.
Find out if your child/loved one qualifies for CALLIOP3, a clinical research study exploring a potential new birth control medication.
Atopic dermatitis is common and affects up to 25% of children. We are inviting you to take part in a clinical study for children and teens between the ages of 12 and 17 years of age, inclusive, who suffer from atopic dermatitis.
Have you considered participating in a clinical research study to learn more about your cardiovascular disease and living healthily?
Clinical trial for children and adolescents (aged 6-17 years) with a history of migraine with and without aura.